Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a “common language” for the new arena of cancer treatment

The recent study by Hodi et al. published in the Journal of Clinical Oncology has evaluated unconventional response patterns during PD-1 inhibitor therapy using immune-related response criteria (irRC) in comparison with RECIST1.1, which constitutes an important step to further understand immune-rela...

Descripción completa

Detalles Bibliográficos
Autor principal: Nishino, Mizuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915158/
https://www.ncbi.nlm.nih.gov/pubmed/27330803
http://dx.doi.org/10.1186/s40425-016-0134-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915158/
https://www.ncbi.nlm.nih.gov/pubmed/27330803
http://dx.doi.org/10.1186/s40425-016-0134-0

Ejemplares similares